Indian Children with Glycogen Storage Disease Registry
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study is creating a registry (a database) to better understand glycogen storage diseases in Indian children. If your child has a confirmed genetic diagnosis, joining helps doctors learn more about the condition and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child was diagnosed with a glycogen storage disease (GSD) before turning 18.
- Genetic testing confirmed a specific gene change causing a type of liver GSD (types 0a, I, III, IV, VI, IX, or XI).
- The diagnosis must be based on a genetic report, not just symptoms or lab tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the natural history (how the illness typically progresses) in people with GSD VI or GSD IX. It may help doctors better understand disease patterns, which can support future treatments.
This study helps doctors diagnose congenital (from birth) glycosylation disorders, which are inherited conditions that affect how the body builds certain sugar-related proteins. You (or your child) may have clinic visits, blood or other samples, and possibly genetic testing—especially if there are family members with a known or suspected condition.
This study follows people with rare types of glycogen storage disease (GSD) over time to learn more about how the disease progresses. It does not test a new treatment but will collect information to help future research.
This study tracks the health of people with type 3 Glycogen storage disease. It may help doctors understand the disease better and plan better care.
This trial is for people who have a confirmed genetic condition related to how the body builds certain sugar-like structures (CDG) or NGLY1 deficiency. It aims to better understand these conditions through clinical and basic science research, which may help improve future care.
This study follows people with rare genetic conditions (GM1, GM2, sialidosis, or galactosialidosis) that affect how the body breaks down certain substances in cells. Researchers track how these diseases progress to better understand them and potentially help future patients.
Hear when a new Glycogen Storage Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.